Isomorphic Labs 完成 5 亿美元 C 轮融资
Isomorphic Labs raised $5 Billion in Series C funding from Greenoaks, Sequoia Capital and Andreessen Horowitz, with continued investment from Alphabet.
由 Demis Hassabis 创立的 AI 制药公司 Isomorphic Labs 完成 5 亿美元 C 轮融资,投资方包括 Greenoaks、Sequoia Capital 和 Andreessen Horowitz,Alphabet 继续参与投资。该公司专注于用 AI 设计和开发新药,Demis Hassabis 称将借此加速其攻克疾病的使命,并缩短发现新药所需的时间与成本。
推荐理由
AI 评分 72
Isomorphic Labs 完成 5 亿美元 C 轮融资,读者可据此了解 AI 制药领域当前的资金规模与主要投资方。
主题
查看原帖非常激动地宣布,@IsomorphicLabs 获得 50 亿美元融资,以加速我们攻克所有疾病的使命。我们正持续取得快速进展,以 AI 从第一性原理出发重新构想药物设计,从而大幅缩短发现新药所需的时间与成本。循序渐进,然后一蹴而就…… https://t.co/ihOS3L9vPC
查看原文
Thrilled to announce $5B in funding for @IsomorphicLabs to accelerate our mission to Solve All Disease. We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines. Gradually, then all at once... https://t.co/ihOS3L9vPC
正文
Isomorphic Labs raised $5 Billion in Series C funding from Greenoaks, Sequoia Capital and Andreessen Horowitz, with continued investment from Alphabet.
> Isomorphic Labs, founded by Demis Hassabis, is focussed on designing and developing new medicines with AI, ushering in a new era of biomedical breakthroughs.
Drug development is a huge area that everyone is expecting to get pushed forward by AI.
Soon? 👀
AI 热点